SUPPLEMENT
Q4 2022 — Financial statement information
Q4 2022PDF · 20 pages306 KB
Three months ended December 31, Year ended December 31, 2022 2021 2022 2021 Net sales $ 8,079 $ 8,612 $ 34,229 $ 35,355 Operating expenses Cost of sales 4,585 4,698 19,232 18,795 Selling, general and administrative expenses 2,146 1,824 9,049 7,197 Research, development and related expenses 445 474 1,862 1,994 (Gain) loss on business divestitures — — (2,724) — Goodwill impairment expense 271 — 271 — Total operating expenses 7,447 6,996 27,690 27,986 Operating income 632 1,616 6,539 7,369 Other expense (income), net 35 52 147 165 Income before income taxes 597 1,564 6,392 7,204 Provision for income taxes 62 227 612 1,285 Income of consolidated group 535 1,337 5,780 5,919 Income (loss) from unconsolidated subsidiaries, net of taxes 8 3 11 10 Net income including noncontrolling interest 543 1,340 5,791 5,929 Less: Net income (loss) attributable to noncontrolling interest 2 1 14 8 Net income attributable to 3M $ 541 $ 1,339 $ 5,777 $ 5,921 Weighted average 3M common shares outstanding – basic 551.9 574.9 566.0 579.0 Earnings per share attributable to 3M common shareholders – basic $ 0.98 $ 2.33 $ 10.21 $ 10.23 Weighted average 3M common shares outstanding – diluted 552.9 579.9 567.6 585.3 Earnings per share attributable to 3M common shareholders – diluted $ 0.98 $ 2.31 $ 10.18 $ 10.12 3M Company and Subsidiaries CONSOLIDATED STATEMENT OF INCOME (Millions, except per-share amounts) (Unaudited) -- 1 of 20 -- December 31, 2022 December 31, 2021 ASSETS Current assets Cash and cash equivalents $ 3,655 $ 4,564 Marketable securities – current 238 201 Accounts receivable – net 4,532 4,660 Inventories 5,372 4,985 Prepaids 435 654 Other current assets 456 339 Total current assets 14,688 15,403 Property, plant and equipment – net 9,178 9,429 Operating lease right of use assets 829 858 Goodwill and intangible assets – net 17,489 18,774 Other assets 4,271 2,608 Total assets $ 46,455 $ 47,072 LIABILITIES AND EQUITY Current liabilities Short-term borrowings and current portion of long-term debt $ 1,938 $ 1,307 Accounts payable 3,183 2,994 Accrued payroll 692 1,020 Accrued income taxes 259 260 Operating lease liabilities – current 261 263 Other current liabilities 3,190 3,191 Total current liabilities 9,523 9,035 Long-term debt 14,001 16,056 Other liabilities 8,161 6,864 Total liabilities 31,685 31,955 Total equity 14,770 15,117 Shares outstanding December 31, 2022: 549,245,105 December 31, 2021: 571,845,478 Total liabilities and equity $ 46,455 $ 47,072 3M Company and Subsidiaries CONDENSED CONSOLIDATED BALANCE SHEET (Dollars in millions) (Unaudited) -- 2 of 20 -- Year ended December 31, 2022 2021 NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES $ 5,591 $ 7,454 Cash flows from investing activities: Purchases of property, plant and equipment (1,749) (1,603) Purchases and proceeds from sale or maturities of marketable securities and investments – net 11 204 Proceeds from sale of businesses, net of cash sold 13 — Cash payment from Food Safety business split-off, net of divested cash 478 — Other investing activities 201 82 NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES (1,046) (1,317) Cash flows from financing activities: Change in debt (838) (1,145) Purchases of treasury stock (1,464) (2,199) Proceeds from issuances of treasury stock pursuant to stock option and benefit plans 381 639 Dividends paid to shareholders (3,369) (3,420) Other financing activities (60) (20) NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES (5,350) (6,145) Effect of exchange rate changes on cash and cash equivalents (104) (62) Net increase (decrease) in cash and cash equivalents (909) (70) Cash and cash equivalents at beginning of year 4,564 4,634 Cash and cash equivalents at end of period $ 3,655 $ 4,564 3M Company and Subsidiaries CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Dollars in millions) (Unaudited) -- 3 of 20 -- Three months ended December 31, 2021 GAAP $ 490 17.2 % $ 376 17.2 % $ 1,616 18.8 % $ 1,564 $ 227 14.5 % $ 1,339 $ 2.31 Adjustments for special items: Net costs for significant litigation 72 — 104 104 24 80 0.14 Three months ended December 31, 2021 adjusted amounts (non-GAAP measures) (a) $ 562 19.7 % $ 376 17.2 % $ 1,720 20.0 % $ 1,668 $ 251 15.1 % $ 1,419 $ 2.45 Three months ended December 31, 2022 GAAP $ 618 22.6 % $ (434) (21.1) % $ 632 7.8 % $ 597 $ 62 10.5 % $ 541 $ 0.98 (58) % Adjustments for special items: Net costs for significant litigation (7) — 58 58 20 38 0.07 Divestiture costs — — 54 54 11 43 0.08 PFAS manufacturing exit costs — 800 800 800 162 638 1.15 Total special items (7) 800 912 912 193 719 1.30 Three months ended December 31, 2022 adjusted amounts (non-GAAP measures) (a) $ 611 22.4 % $ 366 17.8 % $ 1,544 19.1 % $ 1,509 $ 255 16.9 % $ 1,260 $ 2.28 (7) % Year ended December 31, 2021 GAAP 2,466 20.6 % $ 1,880 20.3 % $ 7,369 20.8 % $ 7,204 $ 1,285 17.8 % $ 5,921 $ 10.12 Adjustments for special items: Net costs for significant litigation 249 — 463 463 104 359 0.61 Year ended December 31, 2021 adjusted amounts (non-GAAP measures) (a) $ 2,715 22.7 % $ 1,880 20.3 % $ 7,832 22.2 % $ 7,667 $ 1,389 18.1 % $ 6,280 $ 10.73 Year ended December 31, 2022 GAAP 1,199 10.3 % $ 1,012 11.4 % $ 6,539 19.1 % $ 6,392 $ 612 9.6 % $ 5,777 $ 10.18 1 % Adjustments for special items: Net costs for significant litigation 1,414 — 2,291 2,291 476 1,815 3.20 Divestiture costs — — 60 60 13 47 0.08 Gain on business divestitures — — (2,724) (2,724) (39) (2,685) (4.73) Divestiture-related restructuring actions — — 41 41 9 32 0.05 Russia exit charges — — 109 109 (2) 111 0.20 PFAS manufacturing exit costs — 800 800 800 162 638 1.12 Total special items 1,414 800 577 577 619 (42) (0.08) Year ended December 31, 2022 adjusted amounts (non-GAAP measures) (a) $ 2,613 22.5 % $ 1,812 20.4 % $ 7,116 20.8 % $ 6,969 $ 1,231 17.7 % $ 5,735 $ 10.10 (6) % Operating Income (Loss) Net Income Attribut able to 3M Earnings per diluted share percent change (Dollars in millions, except per share amounts) Safety and Industrial Safety and Industrial Margin Transport ation and Electronics Transport ation and Electronics Margin Total Company Total Company Margin Income Before Taxes Provision for Income Taxes Effective Tax Rate Earnings per Diluted Share 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (Unaudited) -- 4 of 20 -- (a) In addition to reporting financial results in accordance with U.S. GAAP, 3M also provides non-GAAP measures that adjust for the impacts of special items. Special items for the periods presented include the items described in the section entitled “Description of Special Items”. Operating income (loss), segment operating income (loss), income before taxes, net income, earnings per share, and the effective tax rate are all measures for which 3M provides the reported GAAP measure and a measure adjusted for special items. The adjusted measures are not in accordance with, nor are they a substitute for, GAAP measures. While the Company includes certain items in its measure of segment operating performance, it also considers these non-GAAP measures in evaluating and managing its operations. The Company believes that discussion of results adjusted for special items is useful to investors in understanding underlying business performance, while also providing additional transparency to the special items. Special items impacting operating income (loss) are reflected in Corporate and Unallocated, except as described with respect to net costs for significant litigation and PFAS manufacturing exit costs in the “Description of Special Items” section. The determination of these items may not be comparable to similarly titled measures used by other companies. In the first quarter of 2022, the Company changed the extent of matters and charges/benefits it includes within special items with respect to net costs for significant litigation. Previously, 3M included net costs, when significant, associated with changes in accrued liabilities related to respirator mask/asbestos litigation and PFAS-related other environmental matters, along with the associated tax impacts. The non-GAAP measure changes involved including net costs for litigation related to 3M's Combat Arms Earplugs, expanding net costs to include external legal fees and insurance recoveries associated with the applicable matters in addition to changes in accrued liabilities, and to include all such net costs for the applicable matters, not just when considered significant. The information provided herein reflects the impacts of these changes for all periods presented. Three months ended December 31, Year ended December 31, Major GAAP Cash Flow Categories (dollars in millions) 2022 2021 2022 2021 Net cash provided by (used in) operating activities $ 1,922 $ 2,005 $ 5,591 $ 7,454 Net cash provided by (used in) investing activities (388) 115 (1,046) (1,317) Net cash provided by (used in) financing activities (1,315) (2,412) (5,350) (6,145) 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) -- 5 of 20 -- Three months ended December 31, Year ended December 31, Adjusted Free Cash Flow (non-GAAP measure) (dollars in millions) 2022 2021 2022 2021 Net cash provided by (used in) operating activities $ 1,922 $ 2,005 $ 5,591 $ 7,454 Adjustments for special items: Net costs for significant litigation after-tax payment impacts 178 158 716 362 Divestiture costs after-tax payment impacts 6 — 8 — Divestiture gains - closing cost after tax payment impacts 27 — 27 — Divestiture-related restructuring after-tax payment impacts 24 1 28 6 Russia exit charges after-tax payment impacts — — 2 — TCJA transition tax payment — — 68 77 Total adjustments for special items 235 159 849 445 Adjusted net cash provided by (used in) operating activities (b) 2,157 2,164 6,440 7,899 Purchases of property, plant and equipment (506) (556) (1,749) (1,603) Adjusted free cash flow (b) $ 1,651 $ 1,608 $ 4,691 $ 6,296 Net income attributable to 3M $ 541 $ 1,339 $ 5,777 $ 5,921 Adjustments for special items: Net costs for significant litigation 38 80 1,815 359 Divestiture costs 43 — 47 — (Gain) loss on business divestitures — — (2,685) — Divestiture-related restructuring actions — — 32 — Russia exit charges — — 111 — PFAS manufacturing exit costs 638 — 638 — Total special items 719 80 (42) 359 Adjusted net income attributable to 3M (a) $ 1,260 $ 1,419 $ 5,735 $ 6,280 Adjusted free cash flow conversion (b) 131 % 113 % 82 % 100 % (b) Adjusted net cash provided by (used in) operating activities, adjusted free cash flow and adjusted free cash flow conversion are not defined under U.S. GAAP. Therefore, they should not be considered a substitute for income or cash flow data prepared in accordance with U.S. GAAP and may not be comparable to similarly titled measures used by other companies. The Company defines adjusted net cash provided by (used in) operating activities as net cash provided by operating activities, adjusted for special items. The Company defines adjusted free cash flow as adjusted net cash provided by (used in) operating activities less purchases of property, plant and equipment. Cash payments associated with special items in the determination of adjusted net cash provided by (used in) operating activities are reflected net of applicable tax using the U.S. statutory corporate tax rate during the period of payment. It should not be inferred that the entire adjusted free cash flow amount is available for discretionary expenditures. The Company defines adjusted free cash flow conversion as adjusted free cash flow divided by net income attributable to 3M, adjusted for special items. Special items for the periods presented include the items described in section entitled “Description of Special Items”. The Company believes adjusted net cash provided by (used in) operating activities, adjusted free cash flow and adjusted free cash flow conversion are meaningful to investors as they are useful measures of performance and the Company uses these measures as an indication of the strength of the Company and its ability to generate cash. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) -- 6 of 20 -- Adjusted EBITDA (non-GAAP measure) (c) Adjusted EBITDA Margin (non-GAAP measure) (c) Three months ended December 31, Year ended December 31, Three months ended December 31, Year ended December 31, (Dollars in millions) 2022 2021 2022 2021 2022 2021 2022 2021 Safety and Industrial $ 752 $ 715 $ 3,179 $ 3,308 27.5 % 25.1 % 27.4 % 27.6 % Transportation and Electronics 474 487 2,222 2,299 23.0 % 22.3 % 25.0 % 24.8 % Health Care 583 674 2,438 2,673 28.5 % 30.7 % 29.0 % 31.1 % Consumer 261 334 1,142 1,309 20.9 % 24.0 % 21.5 % 23.7 % Corporate and Unallocated (66) 17 (34) 158 Total Company $ 2,004 $ 2,227 $ 8,947 $ 9,747 24.8 % 25.9 % 26.1 % 27.6 % Three months ended December 31, Year ended December 31, Adjusted EBITDA (non-GAAP measure) (dollars in millions) 2022 2021 2022 2021 Net sales $ 8,079 $ 8,612 $ 34,229 $ 35,355 Net income attributable to 3M 541 1,339 5,777 5,921 Add/(subtract): Net income/(loss) attributable to noncontrolling interest 2 1 14 8 (Income)/loss from unconsolidated subsidiaries, net of taxes (8) (3) (11) (10) Provision for income taxes 62 227 612 1,285 Other expense/(income): Interest (Income)/expense 84 110 395 462 Pension & OPEB non-service cost (benefit) (49) (58) (248) (297) Depreciation and amortization expense 460 507 1,831 1,915 Adjustments for special items: Net costs for significant litigation 58 104 2,291 463 Divestiture costs 54 — 60 — (Gain) loss on business divestitures — — (2,724) — Divestiture-related restructuring actions — — 41 — Russia exit charges — — 109 — PFAS manufacturing exit costs 800 — 800 — Total special items 912 104 577 463 Adjusted EBITDA (c) $ 2,004 $ 2,227 $ 8,947 $ 9,747 Adjusted EBITDA margin (c) 24.8 % 25.9 % 26.1 % 27.6 % 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) -- 7 of 20 -- Adjusted EBITDA (non-GAAP measure) Three months ended December 31, 2022 (dollars in millions) Safety and Industrial Transportation and Electronics Health Care Consumer Corporate and Unallocated Total Company Net sales $ 2,735 $ 2,055 $ 2,042 $ 1,246 $ 1 $ 8,079 Business segment operating income (loss) (measure of segment operating performance) $ 618 $ (434) $ 421 $ 224 $ (197) $ 632 Add/(subtract): Depreciation and amortization 141 108 162 37 12 460 Adjustments for special items: Net costs for significant litigation (7) — — — 65 58 Divestiture costs — — — — 54 54 (Gain) loss on business divestitures — — — — — — PFAS manufacturing exit costs — 800 — — — 800 Total special items $ (7) 800 — — $ 119 912 Adjusted EBITDA (non-GAAP measure) (c) $ 752 $ 474 $ 583 $ 261 $ (66) $ 2,004 Adjusted EBITDA margin (non-GAAP measure) (c) 27.5 % 23.0 % 28.5 % 20.9 % 24.8 % Adjusted EBITDA (non-GAAP measure) Three months ended December 31, 2021 (dollars in millions) Safety and Industrial Transportation and Electronics Health Care Consumer Corporate and Unallocated Total Company Net sales $ 2,848 $ 2,184 $ 2,190 $ 1,390 $ — $ 8,612 Business segment operating income (measure of segment operating performance) $ 490 $ 376 $ 515 $ 295 $ (60) $ 1,616 Add/(subtract): Depreciation and amortization 153 111 159 39 45 507 Adjustments for special items: Net costs for significant litigation 72 — — — 32 104 Total special items 72 — — — 32 104 Adjusted EBITDA (non-GAAP measure) (c) $ 715 $ 487 $ 674 $ 334 $ 17 $ 2,227 Adjusted EBITDA margin (non-GAAP measure) (c) 25.1 % 22.3 % 30.7 % 24.0 % 25.9 % 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) -- 8 of 20 -- Adjusted EBITDA (non-GAAP measure) Year ended December 31, 2022 (dollars in millions) Safety and Industrial Transportation and Electronics Health Care Consumer Corporate and Unallocated Total Company Net sales $ 11,604 $ 8,902 $ 8,421 $ 5,298 $ 4 $ 34,229 Business segment operating income (loss) (measure of segment operating performance) $ 1,199 $ 1,012 $ 1,815 $ 994 $ 1,519 $ 6,539 Add/(subtract): Depreciation and amortization 566 410 623 148 84 1,831 Adjustments for special items: Net costs for significant litigation 1,414 — — — 877 2,291 Divestiture costs — — — — 60 60 Gain on business divestitures — — — — (2,724) (2,724) Divestiture-related restructuring actions — — — — 41 41 Russia exit charges — — — — 109 109 PFAS manufacturing exit costs — 800 — — — 800 Total special items 1,414 800 — — (1,637) 577 Adjusted EBITDA (non-GAAP measure) (c) $ 3,179 $ 2,222 $ 2,438 $ 1,142 $ (34) $ 8,947 Adjusted EBITDA margin (non-GAAP measure) (c) 27.4 % 25.0 % 29.0 % 21.5 % 26.1 % Adjusted EBITDA (non-GAAP measure) Year ended December 31, 2021 (dollars in millions) Safety and Industrial Transportation and Electronics Health Care Consumer Corporate and Unallocated Total Company Net sales $ 11,981 $ 9,262 $ 8,597 $ 5,513 $ 2 $ 35,355 Business segment operating income (measure of segment operating performance) $ 2,466 $ 1,880 $ 2,037 $ 1,162 $ (176) $ 7,369 Add/(subtract): Depreciation and amortization 593 419 636 147 120 1,915 Adjustments for special items: Net costs for significant litigation 249 — — — 214 463 Total special items 249 — — — 214 $ 463 Adjusted EBITDA (non-GAAP measure) (c) $ 3,308 $ 2,299 $ 2,673 $ 1,309 $ 158 $ 9,747 Adjusted EBITDA margin (non-GAAP measure) (c) 27.6 % 24.8 % 31.1 % 23.7 % 27.6 % (c) Adjusted EBITDA and adjusted EBITDA margin are not defined under U.S. GAAP. Therefore, adjusted EBITDA and adjusted EBITDA margin should not be considered a substitute for other measures prepared in accordance with U.S. GAAP and may not be comparable to similarly titled measures used by other companies. The Company defines adjusted EBITDA as net income attributable to 3M, adjusted for net income/(loss) attributable to noncontrolling interest, (income)/loss from unconsolidated subsidiaries, provision for income taxes, other expense/(income), depreciation and amortization expense, and special items. For business segments, the Company defines adjusted EBITDA as business segment operating income (loss) (3M’s measure of segment operating performance) adjusted for depreciation and amortization expense and special items. The Company defines adjusted EBITDA margin as adjusted EBITDA divided by net sales. Special items for the periods presented include the items described in the section entitled “Description of Special Items”. The Company considers these non-GAAP measures in evaluating and managing the Company’s operations. The Company believes adjusted EBITDA and adjusted EBITDA margin are meaningful to investors as they provide useful analyses of ongoing underlying operating trends. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) -- 9 of 20 -- Net Debt (non-GAAP measure) December 31, 2022 December 31, 2021 Total debt $ 15,939 $ 17,363 Less: Cash, cash equivalents and marketable securities 3,916 4,792 Net debt (d) $ 12,023 $ 12,571 (d) Net debt is not defined under U.S. GAAP and may not be computed the same as similarly titled measures used by other companies. The Company defines net debt as total debt less the total of cash, cash equivalents and current and long-term marketable securities. 3M believes net debt is meaningful to investors as 3M considers net debt and its components to be an important indicator of liquidity and a guiding measure of capital structure strategy. Description of Special Items: In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP measures that incorporate adjustments for the impacts of special items. Special items incorporated in the preparation of these non-GAAP measures for the periods presented include the items described below: Net costs for significant litigation: • These relate to 3M's respirator mask/asbestos, PFAS-related other environmental, and Combat Arms Earplugs matters. Net costs include the impacts of changes in accrued liabilities, external legal fees, and insurance recoveries, along with the associated tax impacts. Prior to initiating voluntary chapter 11 bankruptcy proceedings in July 2022, net costs related to Combat Arms Earplugs and Aearo-respirator mask/asbestos matters along with non-Aearo respirator mask/ asbestos matters were reflected as special items in the Safety and Industrial business segment. During the bankruptcy period, net costs related to Combat Arms Earplugs and Aearo-respirator mask/asbestos matters are reflected as corporate special items in Corporate and Unallocated. In the fourth quarter of 2022 and 2021, 3M made payments of approximately $226 million and $200 million, respectively, related to net costs for significant litigation. In the full year of 2022 and 2021, 3M made payments of approximately $907 million and $458 million, respectively, related to net costs for significant litigation. Divestiture costs: • These include costs related to separating and divesting substantially an entire business segment of 3M following public announcement of its intended divestiture. In the fourth quarter and full year of 2022, 3M made payments of approximately $8 million and $11 million, respectively, associated with divestiture costs. Gain/loss on sale of businesses divestitures: • In 2022, 3M recorded a pre-tax gain of $2.7 billion ($2.7 billion after tax) related to the split-off and combination of its Food Safety business with Neogen Corporation. In the fourth quarter and full year of 2022, 3M made payments of approximately $34 million related to closing costs of the transaction that were part of the determination of the gain thereon. Divestiture-related restructuring actions: • In the third quarter of 2022, following the split-off of the Food Safety business, management approved and committed to undertake certain restructuring actions addressing corporate functional costs across 3M in relation to the magnitude of amounts previously allocated to the divested business. In the fourth quarter of 2022 and 2021, 3M made payments of approximately $29 million and $1 million, respectively, associated with divestiture-related restructuring actions. In the full year of 2022 and 2021, 3M made payments of approximately $34 million and $8 million, respectively, associated with divestiture-related restructuring actions. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) -- 10 of 20 -- Russia exit charges: • In 2022, 3M recorded a charge primarily related to impairment of net assets in Russia in connection with management’s committed exit and disposal plan. In the fourth quarter and full year of 2022, 3M made payments of approximately $1 million and $3 million, respectively, related to Russia exit charges. Enactment/measurement period adjustments related to the Tax Cuts and Jobs Act (TCJA) • In the full year of 2022 and 2021, 3M made payments of approximately $68 million and $77 million, related to the transition tax expense incurred as a result of the 2017 enactment of the TCJA. PFAS manufacturing exit costs: • These costs relate to 3M's December 2022 commitment to a plan to exit PFAS manufacturing by the end of 2025. Charges for the applicable period relate to asset impairments. These charges were reflected within the Transportation and Electronics business segment. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) -- 11 of 20 -- Three months ended December 31, 2022 Sales Change Analysis By Geographic Area Americas Asia Pacific Europe, Middle East and Africa Worldwide Organic sales 1.4 % (2.6) % 2.0 % 0.4 % Divestitures (1.6) (1.1) (2.2) (1.6) Translation (0.4) (9.5) (10.7) (5.0) Total sales change (0.6) % (13.2) % (10.9) % (6.2) % Year ended December 31, 2022 Sales Change Analysis By Geographic Area Americas Asia Pacific Europe, Middle East and Africa Worldwide Organic sales 2.6 % 0.3 % (0.6) % 1.2 % Divestitures (0.6) (0.4) (0.6) (0.5) Translation (0.3) (6.5) (9.8) (3.9) Total sales change 1.7 % (6.6) % (11.0) % (3.2) % Three months ended December 31, 2022 Worldwide Sales Change By Business Segment Organic sales Acquisitions Divestitures Translation Total sales change Safety and Industrial 1.3 % — % — % (5.3) % (4.0) % Transportation and Electronics 1.4 — (1.1) (6.2) (5.9) Health Care 1.9 — (4.1) (4.5) (6.7) Consumer (5.7) — (1.6) (3.1) (10.4) Total Company 0.4 — (1.6) (5.0) (6.2) Year ended December 31, 2022 Worldwide Sales Change By Business Segment Organic sales Acquisitions Divestitures Translation Total sales change Safety and Industrial 1.0 % — % — % (4.2) % (3.2) % Transportation and Electronics 1.2 — (0.5) (4.6) (3.9) Health Care 3.2 — (1.4) (3.8) (2.0) Consumer (0.9) — (0.4) (2.6) (3.9) Total Company 1.2 — (0.5) (3.9) (3.2) (e) Total sales change is calculated based on reported sales results. The components of sales change include organic local- currency sales, acquisitions, divestitures, and translation. Organic local-currency sales include both organic volume impacts (which excludes acquisition and divestiture impacts) and selling price changes. Acquisition and divestiture impacts are measured separately for the first 12 months post-transaction. 3M Company and Subsidiaries SALES CHANGE ANALYSIS (e) (Unaudited) -- 12 of 20 -- 3M discloses business segment operating income as its measure of segment profit/loss, reconciled to both total 3M operating income and income before taxes. Business segment operating income excludes certain expenses and income that are not allocated to business segments (as described below in “Corporate and Unallocated”). Effective in the first quarter of 2022, the measure of segment operating performance used by 3M’s chief operating decision maker (CODM) changed and, as a result, 3M’s disclosed measure of segment profit/loss (business segment operating income) was updated. The change to business segment operating income aligns with the update to how the CODM assesses performance and allocates resources for the Company’s business segments. The changes included the items described below. The financial information presented herein reflects the impact of these business segment reporting changes for all periods presented. Eliminating inclusion of dual credit in measure of segment operating performance 3M business segment operating performance measures were updated to no longer include dual credit to business segments for certain sales and related operating income. Management previously evaluated its business segments based on net sales and operating income performance, including dual credit reporting. 3M reflected additional (“dual”) credit to another business segment when the customer account activity (“sales district”) with respect to the particular product sold to the external customer was provided by a different business segment. For example, privacy screen protection products are primarily sold by the Display Materials and Systems Division within the Transportation and Electronics business segment; however, certain sales districts within the Consumer business segment provide the customer account activity for sales of the product to particular customers. In this example, the non-primary selling segment (Consumer) previously would also have received credit for the associated net sales initiated through its sales district and the related approximate operating income. The offset to the dual credit business segment reporting was reflected as a reconciling item entitled “Elimination of Dual Credit,” such that sales and operating income in total were unchanged. Reflecting certain litigation-related costs in the Safety and Industrial segment's operating performance measure 3M's business segment operating performance measure with respect to its Safety and Industrial business segment was updated relative to litigation-related costs for non-Aearo and Aearo respirator respirator mask/asbestos litigation matters. Previously, 3M included these costs, when significant, as a special item within Corporate and Unallocated. 3M changed to include all litigation-related costs associated with respirator mask/asbestos litigation matters (along with other Safety and Industrial matters already included therein, such as those related to Combat Arms Earplugs) within the Safety and Industrial business segment. Note, however, that prospectively during the Aearo chapter 11 bankruptcy period (which began in July 2022) net costs for significant litigation associated with Combat Arms Earplugs and Aearo-respirator mask/ asbestos matters are reflected in Corporate and Unallocated. BUSINESS SEGMENT INFORMATION Three months ended December 31, Year ended December 31, NET SALES (Millions) 2022 2021 2022 2021 Safety and Industrial $ 2,735 $ 2,848 $ 11,604 $ 11,981 Transportation and Electronics 2,055 2,184 8,902 9,262 Health Care 2,042 2,190 8,421 8,597 Consumer 1,246 1,390 5,298 5,513 Corporate and Unallocated 1 — 4 2 Total Company $ 8,079 $ 8,612 $ 34,229 $ 35,355 3M Company and Subsidiaries BUSINESS SEGMENTS (Unaudited) -- 13 of 20 -- BUSINESS SEGMENT INFORMATION Three months ended December 31, Year ended December 31, OPERATING INCOME (LOSS) (Millions) 2022 2021 2022 2021 Safety and Industrial $ 618 $ 490 $ 1,199 $ 2,466 Transportation and Electronics (434) 376 1,012 1,880 Health Care 421 515 1,815 2,037 Consumer 224 295 994 1,162 Total business segment operating income (loss) 829 1,676 5,020 7,545 Corporate and Unallocated Corporate special items: Net costs for significant litigation (65) (32) (877) (214) Divestiture costs (54) — (60) — (Gain) loss on business divestitures — — 2,724 — Divestiture-related restructuring actions — — (41) — Russia exit charges — — (109) — Total corporate special items (119) (32) 1,637 (214) Other corporate expense - net (78) (28) (118) 38 Total Corporate and Unallocated (197) (60) 1,519 (176) Total Company operating income 632 1,616 6,539 7,369 Other expense/(income), net 35 52 147 165 Income before income taxes $ 597 $ 1,564 $ 6,392 $ 7,204 Corporate and Unallocated Corporate and Unallocated operating income includes “corporate special items” and “other corporate expense-net”. Corporate special items include net costs for significant litigation associated with Combat Arms Earplugs and Aearo-respirator mask/ asbestos matters during the chapter 11 bankruptcy period (which began in July 2022) and with PFAS-related other environmental matters. Corporate special items also include divestiture costs, gain/loss on business divestitures, divestiture- related restructuring costs, and Russia exit costs. Divestiture costs include costs related to separating and divesting substantially an entire business segment of 3M following public announcement of its intended divestiture. Other corporate expense-net includes items such as net costs related to limited unallocated corporate staff and centrally managed material resource centers of expertise costs, corporate philanthropic activity, and other net costs that 3M may choose not to allocate directly to its business segments. Other corporate expense-net also includes costs and income from transition supply, manufacturing, and service arrangements with Neogen Corporation following the 2022 split-off of 3M's Food Safety business and with the acquirer of the former Drug Delivery business following its 2020 divestiture. Items classified as revenue from this activity are included in Corporate and Unallocated net sales. Because Corporate and Unallocated includes a variety of miscellaneous items, it is subject to fluctuation on a quarterly and annual basis. 3M Company and Subsidiaries BUSINESS SEGMENTS - (CONTINUED) (Unaudited) -- 14 of 20 -- Beginning in 2023, 3M is changing certain of its non-GAAP measures. As a result, 3M’s 2023 outlook expectations herein reflect measures on that basis. Relevant 2023 non-GAAP measure changes include: • Adjusting for the results of manufactured PFAS products in arriving at results, adjusted for special items — In the fourth quarter of 2022, 3M included an adjustment for PFAS manufacturing exit costs. The non-GAAP measure change involves expanding the extent of adjustment to include the sales and estimates of income (including exit costs) and associated activity regarding manufactured PFAS products that 3M plans to exit by the end of 2025. The discussion and tables below provides relevant 2023 outlook expectation non-GAAP measures and prior period non-GAAP measure information on this new basis. Full Year 2023 Forecast 2023 adjusted earnings per share — new outlook basis (non-GAAP measure)* (f) $8.50 to $9.00 2023 adjusted effective tax rate — new outlook basis (non-GAAP measure)* (f) 18 % to 19 % * 3M cannot, without unreasonable effort, forecast certain items required to develop meaningful comparable GAAP financial measures and, therefore, does not provide them on a forward-looking basis reflecting these items. These include special items on a 2023 outlook basis such as net costs for significant litigation; projected divestiture gains; divestiture costs; divestiture-related restructuring; and net sales and estimates of income and associated activity of exited manufactured PFAS products. This is due to limitations in predicting with reasonable certainty items such as the timing and ultimate outcome of significant litigation, certain conditions outside of 3M’s control regarding divestitures, the meaningful amount and timing of costs involved over the duration of an announced segment-sized divestiture, the timing of customer re- sourcing of product as 3M winds down PFAS manufacturing, and numerous other conditions outside of 3M’s control. 3M believes these limitations would result in a range of projected values so broad as to not be meaningful to investors. For these reasons, 3M believes that the probable significance of such information is low. Additionally, for similar reasons, 3M does not include the impact of potentially-divested or acquired businesses on expected operations in the forecasted outlook guidance it provides until close of a transaction. Information with respect to special items on a 2023 outlook basis for certain relevant historical periods is included herein in this “Supplemental Financial Information Non-GAAP Measures — New Outlook Basis” section. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES - NEW OUTLOOK BASIS (Unaudited) -- 15 of 20 -- (Dollars in millions, except per share amounts) Sales Sales Change Income Before Taxes Provision for Income Taxes Effective tax rate Net Income Attributabl e to 3M Earnings per Diluted Share Year ended December 31, 2021 GAAP $ 35,355 $ 7,204 $ 1,285 17.8 % $ 5,921 10.12 Adjustments for special items — new outlook basis: Net costs for significant litigation $ 463 $ 104 $ 359 $ 0.61 Manufactured PFAS products (1,258) (135) (29) (106) (0.18) Total special items — new outlook basis (1,258) 328 75 253 0.43 Year ended December 31, 2021 adjusted amounts — new outlook basis (non-GAAP measures) (f) $ 34,097 $ 7,532 $ 1,360 18.1 % $ 6,174 10.55 Year ended December 31, 2022 GAAP $ 34,229 $ 6,392 $ 612 9.6 % $ 5,777 10.18 Adjustments for special items — new outlook basis: Net costs for significant litigation 2,291 476 1,815 3.20 Divestiture costs 60 13 47 0.08 Gain on business divestitures (2,724) (39) (2,685) (4.73) Divestiture-related restructuring actions 41 9 32 0.05 Russia exit charges 109 (2) 111 0.20 Manufactured PFAS products (1,351) 631 121 510 0.90 Total special items — new outlook basis (1,351) 408 — 578 (170) (0.30) Year ended December 31, 2022 adjusted amounts — new outlook basis (non-GAAP measures) (f) $ 32,878 (3.6) % $ 6,800 $ 1,190 17.5 % $ 5,607 9.88 (f) In addition to reporting financial results in accordance with U.S. GAAP, 3M also provides non-GAAP measures that adjust for the impacts of special items as defined on a 2023 outlook basis. Special items on a 2023 outlook basis for the periods presented include the items described in the section entitled “Description of Special Items — New Outlook Basis”. Net sales (and sales change), income before taxes, the effective tax rate, net income, and earnings per share, are all measures for which 3M provides the reported GAAP measure and a measure adjusted for special items on a 2023 outlook basis. The adjusted measures are not in accordance with, nor are they a substitute for, GAAP measures. The Company considers these non-GAAP measures in evaluating and managing its operations. The Company believes that discussion of results adjusted for special items on a 2023 outlook basis is useful to investors in understanding underlying business performance including in relation to 2023 outlook, while also providing additional transparency to the special items. The determination of these items may not be comparable to similarly titled measures used by other companies. Year ended December 31, Major GAAP Cash Flow Categories (dollars in millions) 2022 2021 Net cash provided by (used in) operating activities $ 5,591 $ 7,454 Net cash provided by (used in) investing activities (1,046) (1,317) Net cash provided by (used in) financing activities (5,350) (6,145) 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES - NEW OUTLOOK BASIS- (CONTINUED) (Unaudited) -- 16 of 20 -- (Dollars in billions) Full Year 2023 Forecast Net cash provided by (used in) operating activities* $5.8 to $6.3 Adjustments for special items — new outlook basis* — Adjusted net cash provided by (used in) Operating activities — new outlook basis* $5.8 to $6.3 Purchase of property, plant and equipment (PPE) ($1.5 to $1.8) Manufactured PFAS products impact — removing related purchases of PPE ~$0.2 Adjusted free cash flow — new outlook basis* (g) $4.2 to $5.0 Net income attributable to 3M* $4.7 to $5.0 Adjustments for special items — new outlook basis* — Adjusted net income attributable to 3M — new outlook basis* (f) $4.7 to $5.0 Adjusted free cash flow conversion — new outlook basis* (g) 90% to 100% 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES - NEW OUTLOOK BASIS- (CONTINUED) (Unaudited) -- 17 of 20 -- Year ended December 31, Adjusted Free Cash Flow — new outlook basis (non-GAAP measure) (dollars in millions) 2022 2021 Net cash provided by (used in) operating activities $ 5,591 $ 7,454 Adjustments for special items — new outlook basis: Net costs for significant litigation after-tax payment impacts 716 362 Divestiture costs after-tax payment impacts 8 — Divestiture gains - closing cost after tax payment impacts 27 — Divestiture-related restructuring after-tax payment impacts 28 6 Russia exit charges after-tax payment impacts 2 — TCJA transition tax payment 68 77 Manufactured PFAS products impact (36) (166) Total adjustments for special items — new outlook basis 813 279 Adjusted net cash provided by (used in) operating activities — new outlook basis (g) 6,404 7,733 Purchases of property, plant and equipment (PPE) (1,749) (1,603) Manufactured PFAS products impact — removing related purchases of PPE 175 124 Adjusted free cash flow — new outlook basis (g) $ 4,830 $ 6,254 Net income attributable to 3M $ 5,777 $ 5,921 Adjustments for special items — new outlook basis: Net costs for significant litigation 1,815 359 Divestiture costs 47 — (Gain) loss on business divestitures (2,685) — Divestiture-related restructuring actions 32 — Russia exit charges 111 — Manufactured PFAS products 510 (106) Total special items — new outlook basis (170) 253 Adjusted net income attributable to 3M — new outlook basis (f) $ 5,607 $ 6,174 Adjusted free cash flow conversion — new outlook basis (g) 86 % 101 % (g) Adjusted net cash provided by (used in) operating activities, adjusted free cash flow and adjusted free cash flow conversion all on a 2023 outlook basis are not defined under U.S. GAAP. Therefore, they should not be considered a substitute for income or cash flow data prepared in accordance with U.S. GAAP and may not be comparable to similarly titled measures used by other companies. The Company defines adjusted net cash provided by (used in) operating activities — new outlook basis as net cash provided by operating activities, adjusted for special items on a 2023 outlook basis. The Company defines adjusted free cash flow — new outlook basis as adjusted net cash provided by (used in) operating activities — new outlook basis less purchases of property, plant and equipment (PPE) adjusted for the estimated impact of such purchases associated with manufactured PFAS products activity. Cash payments associated with special items in the determination of adjusted net cash provided by (used in) operating activities — new outlook basis are reflected net of applicable tax using the U.S. statutory corporate tax rate during the period of payment. It should not be inferred that the entire adjusted free cash flow amount is available for discretionary expenditures. The Company defines adjusted free cash flow conversion — new outlook basis as adjusted free cash flow — new outlook basis divided by net income attributable to 3M, adjusted for special items on a 2023 outlook basis. Special items on a 2023 outlook basis for the periods presented include the items described in the section entitled “Description of Special Items — New Outlook Basis”. The Company believes adjusted net cash provided by (used in) operating activities, adjusted free cash flow and adjusted free cash flow conversion all on a 2023 outlook basis are meaningful to investors as they are useful measures of performance and the Company uses these measures as an indication of the strength of the Company and its ability to generate cash. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES - NEW OUTLOOK BASIS- (CONTINUED) (Unaudited) -- 18 of 20 -- Full-Year 2023 Forecast Worldwide Sales Change (e) Organic sales Acquisitions Divestitures Translation Total sales change Total Company* (3)% to flat % — % (1)% (2)% to (1)% (6)% to (2)% Remove manufactured PFAS products impact* — % — % — % — % — % Adjusted total Company — new outlook basis (non-GAAP measures)* (f) (3)% to flat % (1)% (2)% to (1)% (6)% to (2)% Year ended December 31, 2022 Worldwide Sales Change (e) Organic sales Acquisitions Divestitures Translation Total sales change Total Company 1.2 % — % (0.5) % (3.9) % (3.2) % Remove manufactured PFAS products impact (0.4) % — % — % — % (0.4) % Adjusted total Company — new outlook basis (non- GAAP measures) (f) 0.8 % (0.5) % (3.9) % (3.6) % Description of Special Items — New Outlook Basis: In addition to reporting financial results in accordance with U.S. GAAP, 3M also provides relevant non-GAAP measures that adjust for the impacts of special items as defined on a 2023 outlook basis. Relevant special items on a 2023 outlook basis for the periods presented include the items described below. These items align with those included in the section “Supplemental Financial Information — Non-GAAP Measures, Description of Special Items” which is largely repeated below, with the exception of the expansion of the extent of adjustment relative to PFAS manufactured products to include the sales and estimates of income (including exit costs) and associated activity regarding manufactured PFAS products that 3M plans to exit by the end of 2025. Net costs for significant litigation: • These relate to 3M's respirator mask/asbestos, PFAS-related other environmental, and Combat Arms Earplugs matters. Net costs include the impacts of changes in accrued liabilities, external legal fees, and insurance recoveries, along with the associated tax impacts. Prior to initiating voluntary chapter 11 bankruptcy proceedings in July 2022, net costs related to Combat Arms Earplugs and Aearo-respirator mask/asbestos matters along with non-Aearo respirator mask/ asbestos matters were reflected as special items in the Safety and Industrial business segment. During the bankruptcy period, net costs related to Combat Arms Earplugs and Aearo-respirator mask/asbestos matters are reflected as corporate special items in Corporate and Unallocated. In 2022 and 2021, 3M made payments of approximately $907 million and $458 million, respectively, related to net costs for significant litigation. Divestiture costs: • These include costs related to separating and divesting substantially an entire business segment of 3M following public announcement of its intended divestiture. In the 2022, 3M made payments of approximately $11 million associated with divestiture costs. Gain/loss on sale of businesses divestitures: • In 2022, 3M recorded a pre-tax gain of $2.7 billion ($2.7 billion after tax) related to the split-off and combination of its Food Safety business with Neogen Corporation. In 2022, 3M made payments of approximately $34 million related to closing costs of the transaction that were part of the determination of the gain thereon. Divestiture-related restructuring actions: • In the third quarter of 2022, following the split-off of the Food Safety business, management approved and committed to undertake certain restructuring actions addressing corporate functional costs across 3M in relation to the magnitude 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES - NEW OUTLOOK BASIS- (CONTINUED) (Unaudited) -- 19 of 20 -- of amounts previously allocated to the divested business. In 2022 and 2021, 3M made payments of approximately $34 million and $8 million, respectively, associated with divestiture-related restructuring actions. Russia exit charges: • In 2022, 3M recorded a charge primarily related to impairment of net assets in Russia in connection with management’s committed exit and disposal plan. In 2022, 3M made payments of approximately $3 million related to Russia exit charges. Enactment/measurement period adjustments related to the Tax Cuts and Jobs Act (TCJA) • In 2022 and 2021, 3M made payments of approximately $68 million and $77 million, related to the transition tax expense incurred as a result of the 2017 enactment of the TCJA. Manufactured PFAS products: • These amounts relate to sales and estimates of income and associated activity regarding manufactured PFAS products that 3M plans to exit by the end of 2025 included within the Transportation and Electronics business segment. Estimated income does not contemplate impacts on non-operating items such as net interest income/expense and the non-service cost components of portion defined benefit plan net periodic benefit costs. Relative to the impact of the activity of manufactured PFAS products on cash provided by (used in) operating activities, amounts are based on estimates of associated income, depreciation/amortization, and certain changes in working capital. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES - NEW OUTLOOK BASIS- (CONTINUED) (Unaudited) -- 20 of 20 --